Psoriasis
Atopic Dermatitis
Wound Healing
Skin Grafting
Non-GLP Skin Toxicology
Stroke
Neurodegenerative Diseases (AD’s, PD’s)
Psychopharmacology
CNS-PK
Pulmonary Arterial Hypertension
Ischemia Reperfusion
Heart failures (HFpEF & HFrEF)
Gastrointestinal disorders
Metabolic disturbances
Regulatory food toxicology
ETAP-Lab is compliant with
About us
ETAP-Lab is an independent Contract Research Organization (CRO)
ETAP-Lab provides preclinical pharmacology and research services, as well as scientific expertise, to Pharmaceutical and Agro-Food industries. Our activity focuses on In Vivo models of pathologies and toxicology studies in rodents to support drug and nutraceutic R&D for our sponsors.
Since the foundation in 1991, ETAP-Lab’s Scientists have an in-depth expertise in pathology modeling with rodents. By respecting rodent chronobiology and natural behaviors, ETAP-Lab proposes research models with added translational value. All our models are customizable and original specific models can be set-up and validated on request.
Subscribe to our newsletter
Our News
-
Join us at the annual International Stroke Conference next February in Los Angeles!
📌ETAP-Lab is delighted to present for the first time a poster at the American Heart Association’s annual International Stroke Conference 2025, in Los Angeles, CA from February 5 to 7,
-
ETAP-Lab renews its ISO 9001 certification: Your assurance of quality, reliability and customer satisfaction
We are delighted to announce the renewal of ETAP-Lab's ISO 9001 certification. This achievement underlines our commitment to providing exemplary preclinical research services. A commitment to quality and customer satisfaction Our robust
-
Join us at the 16th World Stroke Congress in Abu Dhabi this October!
🌍ETAP-Lab is happy to present a poster at the 16th World Stroke Congress (WSC 2024) in Abu Dhabi, UAE, from October 23-26, 2024 organized by the World Stroke Organization. ETAP-Lab's team